Mutations occur during the viral growth phase used to prepare inactivated viral vaccines

the verdict

SUPPORTED

the evidence backs this

Recorded sources

4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Mutations can indeed occur and accumulate during the viral growth and passage phases utilized in the preparation of viral vaccines.

The analysis

The retrieved literature consistently supports the claim that mutations arise during the viral growth, adaptation, or passage phases associated with vaccine manufacturing (such as egg-adaptation or replication optimization).

Evidence for · 4

Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens

Recorded source metadata

Zhen Hu, Hui Ai, Zhen Wang, Shiyue Huang, Honglei Sun, Xinxin Xuan, Mingyue Chen, Jinxiu Wang, Wei Yan, Jiayi Sun, Juan Pu, C. Brooke, Kin-Chow Chang, Yipeng Sun, Jinhua Liu. Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens. 2025. https://doi.org/10.1038/s41541-025-01115-y

Paper 1 notes that viral passage and replication in the context of inactivated vaccine production/usage introduce stable mutations that enhance viral replication.

Source citation format

See more details

More for · 3

Neurovirulence.

Recorded source metadata

D Wood. Neurovirulence.. 1999. https://pubmed.ncbi.nlm.nih.gov/10566785/

Paper 8 discusses monitoring the reversion of key mutations that accumulate during the manufacture of poliovirus vaccines.

Source citation format

Flucelvax (Optaflu) for seasonal influenza.

Recorded source metadata

Ilaria Manini, Alexander Domnich, Daniela Amicizia, Stefania Rossi, Teresa Pozzi, Roberto Gasparini, Donatella Panatto, Emanuele Montomoli. Flucelvax (Optaflu) for seasonal influenza.. 2015. https://doi.org/10.1586/14760584.2015.1039520

Paper 9 highlights egg-adaptive viral mutations that occur during conventional influenza vaccine manufacturing.

Source citation format

A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine.

Recorded source metadata

Yujiao Yang, Chao Shan, Jing Zou, Antonio E Muruato, Diniz Nunes Bruno, Barbosa de Almeida Medeiros Daniele, Pedro F C Vasconcelos, Shannan L Rossi, Scott C Weaver, Xuping Xie, Pei-Yong Shi. A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine.. 2017. https://doi.org/10.1016/j.ebiom.2017.02.003

Paper 11 identifies specific viral replication-enhancing mutations introduced during the preparation and high-yield manufacturing of an inactivated Zika vaccine.

Source citation format

The paper trail · every fact has a biography

first checked01 Aug 2026

judged → SUPPORTED · 8401 Aug 2026

More receipts

Is it true that Phonological evolution involves regular processes of phoneme elision, vowel nasalization, and tonogenesis?Is it true that Hemangiomas are treatable with medication?Is it true that Research identifies forms of intelligence that diverge from standard IQ measures?

Random receipt →The Trust Wiki →

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt